No FDA Review for Most Antibody Tests Draws Rebuke from Lawmaker

Published April 24, 2020

Food and Drug Administration (FDA) has allowed antibody tests that could show if someone has already been exposed to Covid-19 and developed some immunity to be on the market without its review and has yet to take an enforcement action, according to lawmakers.

Related Stories